Molecules, Vol. 25, Pages 1672: Novel Anthraquinone Compounds Inhibit Colon Cancer Cell Proliferation via the Reactive Oxygen Species/JNK Pathway
Molecules, Vol. 25, Pages 1672: Novel Anthraquinone Compounds Inhibit Colon Cancer Cell Proliferation via the Reactive Oxygen Species/JNK Pathway
Molecules doi: 10.3390/molecules25071672
Authors:
Yuying Li
Fang Guo
Yingying Guan
Tinggui Chen
Kaiqing Ma
Liwei Zhang
Zhuanhua Wang
Qiang Su
Liheng Feng
Yaoming Liu
Yuzhi Zhou
A series of amide anthraquinone derivatives, an important component of some traditional Chinese medicines, were structurally modified and the resulting antitumor activities were evaluated. The compounds showed potent anti-proliferative activities against eight human cancer cell lines, with no noticeable cytotoxicity towards normal cells. Among the candidate compounds, 1-nitro-2-acyl anthraquinone-leucine (8a) showed the greatest inhibition of HCT116 cell activity with an IC50 of 17.80 μg/mL. In addition, a correlation model was established in a three-dimensional quantitative structure-activity relationship (3D-QSAR) study using Comparative Molecular Field Analysis (CoMFA) and comparative molecular similarity index analysis (CoMSIA). Moreover, compound 8a effectively killed tumor cells by reactive oxygen species (ROS)-JNK activation, causing an increase in ROS levels, JNK phosphorylation, and mitochondrial stress. Cytochrome c was then released into cytoplasm, which, in turn activated the cysteine protease pathway and ultimately induced tumor cell apoptosis, suggesting a potential use of this compound for colon cancer tre...
Source: Molecules - Category: Chemistry Authors: Yuying Li Fang Guo Yingying Guan Tinggui Chen Kaiqing Ma Liwei Zhang Zhuanhua Wang Qiang Su Liheng Feng Yaoming Liu Yuzhi Zhou Tags: Article Source Type: research
More News: Cancer | Cancer & Oncology | Chemistry | China Health | Colon Cancer | Colorectal Cancer | Study